SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-20-000969
Filing Date
2020-03-26
Accepted
2020-03-26 17:25:52
Documents
72
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K phio_10k-123119.htm 10-K 780727
2 DESCRIPTION OF THE REGISTRANT S SECURITIES phio_ex0413.htm EX-4.13 17379
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_ex2301.htm EX-23.1 1904
4 CERTIFICATION phio_ex3101.htm EX-31.1 10678
5 CERTIFICATION phio_ex3201.htm EX-32.1 5268
6 GRAPHIC image_001.jpg GRAPHIC 28550
7 GRAPHIC image_002.jpg GRAPHIC 19082
8 GRAPHIC image_003.jpg GRAPHIC 32701
9 GRAPHIC image_004.jpg GRAPHIC 18369
  Complete submission text file 0001683168-20-000969.txt   3642724

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE phio-20191231.xml EX-101.INS 492258
11 XBRL SCHEMA FILE phio-20191231.xsd EX-101.SCH 37344
12 XBRL CALCULATION FILE phio-20191231_cal.xml EX-101.CAL 56317
13 XBRL DEFINITION FILE phio-20191231_def.xml EX-101.DEF 154958
14 XBRL LABEL FILE phio-20191231_lab.xml EX-101.LAB 308778
15 XBRL PRESENTATION FILE phio-20191231_pre.xml EX-101.PRE 252616
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 20747078
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences